To our knowledge, this case presents a previously unreported triad: euDKA precipitated by influenza A with secondary MSSA pneumonia in a patient on multi-year SGLT2 inhibitor therapy. Here, SLC5A2 is linked to susceptibility to pneumonia measurement.